Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Wave Life Sciences Ltd.

Get SEC filing alerts via email and in your feed for Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd. is a biotechnology company specializing in RNA-based therapeutics using its proprietary PRISM platform. It develops innovative oligonucleotide medicines across modalities like RNA editing, splicing, and silencing to treat rare and common diseases. Its pipeline includes programs for obesity, genetic liver disorders, muscular dystrophy, and neurodegenerative diseases, leveraging chemistry innovations for targeted, durable, and delivery-efficient RNA therapies.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Wave Life Sciences Ltd.

1
1
Wave Life Sciences Ltd. Wave Life Sciences Reports $38.2M Revenue and $26.1M Net Loss for Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Wave Life Sciences Ltd. Wave Life Sciences Reports 2025 Financial Results and Strategic Developments

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Wave Life Sciences Ltd. Wave Life Sciences Reports Q3 2025 Revenue Growth to $7.6 Million Amid Ongoing Losses

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Wave Life Sciences Ltd. Wave Life Sciences Reports Significant Revenue Decline and Increased Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Wave Life Sciences Ltd. Wave Life Sciences Reports $46.9 Million Net Loss in Q1 2025, Revenue Declines to $9.2 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Wave Life Sciences Ltd. Wave Life Sciences Reports $97M Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Wave Life Sciences Ltd. Wave Life Sciences Reports Significant Net Loss and Revenue Decline in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments